Telemus Capital LLC Sells 2,801 Shares of Aflac Incorporated (NYSE:AFL)

Telemus Capital LLC reduced its holdings in shares of Aflac Incorporated (NYSE:AFL) by 33.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,577 shares of the financial services provider’s stock after selling 2,801 shares during the quarter. Telemus Capital LLC’s holdings in Aflac were worth $460,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the business. Fortitude Family Office LLC acquired a new stake in shares of Aflac in the 4th quarter valued at approximately $25,000. Impact Partnership Wealth LLC boosted its holdings in shares of Aflac by 471.4% in the 3rd quarter. Impact Partnership Wealth LLC now owns 400 shares of the financial services provider’s stock valued at $31,000 after buying an additional 330 shares during the last quarter. Bruce G. Allen Investments LLC acquired a new stake in shares of Aflac in the 4th quarter valued at approximately $32,000. Harvest Fund Management Co. Ltd acquired a new stake in shares of Aflac in the 3rd quarter valued at approximately $33,000. Finally, Criterion Capital Advisors LLC acquired a new stake in shares of Aflac in the 4th quarter valued at approximately $33,000. 67.44% of the stock is owned by institutional investors.

Aflac Stock Up 0.3 %

AFL stock opened at $83.52 on Tuesday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.06 and a current ratio of 0.06. The company has a market capitalization of $48.06 billion, a price-to-earnings ratio of 10.78, a PEG ratio of 2.28 and a beta of 0.91. Aflac Incorporated has a fifty-two week low of $64.10 and a fifty-two week high of $86.26. The stock has a fifty day moving average of $82.31 and a 200-day moving average of $81.64.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.25 earnings per share for the quarter, missing the consensus estimate of $1.47 by ($0.22). Aflac had a return on equity of 17.59% and a net margin of 24.92%. The firm had revenue of $3.78 billion for the quarter, compared to the consensus estimate of $4.44 billion. During the same quarter in the previous year, the company posted $1.29 EPS. As a group, equities research analysts predict that Aflac Incorporated will post 6.41 earnings per share for the current year.

Insider Activity

In related news, SVP Albert Riggieri sold 8,000 shares of the firm’s stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $83.34, for a total transaction of $666,720.00. Following the transaction, the senior vice president now directly owns 32,825 shares of the company’s stock, valued at approximately $2,735,635.50. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, Director Thomas J. Kenny sold 5,000 shares of Aflac stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $84.62, for a total transaction of $423,100.00. Following the sale, the director now directly owns 17,920 shares in the company, valued at $1,516,390.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Albert Riggieri sold 8,000 shares of Aflac stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $83.34, for a total value of $666,720.00. Following the sale, the senior vice president now owns 32,825 shares in the company, valued at $2,735,635.50. The disclosure for this sale can be found here. In the last 90 days, insiders sold 46,493 shares of company stock worth $3,765,706. 0.80% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on AFL. The Goldman Sachs Group raised their price target on Aflac from $61.00 to $75.00 and gave the company a “sell” rating in a report on Tuesday, January 9th. Evercore ISI downgraded Aflac from an “in-line” rating to an “underperform” rating and raised their price target for the company from $76.00 to $78.00 in a report on Thursday, January 4th. Piper Sandler raised their price target on Aflac from $90.00 to $95.00 and gave the company an “overweight” rating in a report on Friday, April 5th. UBS Group raised their price target on Aflac from $80.00 to $84.00 and gave the company a “neutral” rating in a report on Wednesday, January 10th. Finally, Morgan Stanley raised their price target on Aflac from $80.00 to $84.00 and gave the company an “equal weight” rating in a report on Monday, April 15th. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company. According to data from MarketBeat, Aflac has a consensus rating of “Hold” and an average target price of $82.15.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.